224 related articles for article (PubMed ID: 29098843)
21. [Reporting standards for expert consensus on clinical practice of Chinese patent medicines of China Association of Chinese Medicine].
Mo M; Liao X; Zhang XX; Li B; Chen W; Zhao GZ; Guo YB
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2644-2651. PubMed ID: 31359735
[TBL] [Abstract][Full Text] [Related]
22. Authentication of Schisandra chinensis and Schisandra sphenanthera in Chinese patent medicines.
Jiang P; Lu Y; Chen D
J Pharm Biomed Anal; 2016 Nov; 131():263-271. PubMed ID: 27611098
[TBL] [Abstract][Full Text] [Related]
23. [Present status and sustainable development of Dendrobium officinale industry].
Wu Y; Si J
Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(15):2033-7. PubMed ID: 20931861
[TBL] [Abstract][Full Text] [Related]
24. [Technical specifications for hospital-based intensive monitoring of post-marketing Chinese patent medicine].
Xie YM; Liao X; Jiang JJ; Zhang YL; Ma R; Zhu MJ; Zhan SY; Liu JP; Liu J; Wen ZH; Yang ZQ; He Y; Li XL
Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2896-2901. PubMed ID: 31602831
[TBL] [Abstract][Full Text] [Related]
25. [Patented technology status quo and development trend for Chinese herbal medicines].
Li C; Huang L
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1468-72. PubMed ID: 19771885
[TBL] [Abstract][Full Text] [Related]
26. [Application prospect of new technology and new equipment in production of Chinese patent medicine].
Tang X; Wu ZF; Sun P; Yi B; Liu XH; Liu ZF; Song MX; Yang M
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(21):4560-4565. PubMed ID: 31872648
[TBL] [Abstract][Full Text] [Related]
27. The distribution of sales revenues from pharmaceutical innovation.
Grabowski HG; Vernon J
Pharmacoeconomics; 2000; 18 Suppl 1():21-32. PubMed ID: 11151306
[TBL] [Abstract][Full Text] [Related]
28. [Construction and practice on rational medication model of Chinese patent medicine for orthopedics based on ″symdrome-dosage-toxicity differentiation″ theory].
Wang YG; Jin R; Qiang SS; Lin ZJ; Li HY; Lu S; Kong XW
Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(2):350-353. PubMed ID: 28861985
[TBL] [Abstract][Full Text] [Related]
29. [Clinical comprehensive evaluation of Chinese patent medicine based on EVIDEM].
Liao X; Dai ZQ; Wu X; Luo H; Zhao H; Zhang XX; Jia LL; Tang JY
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2833-2840. PubMed ID: 35718504
[TBL] [Abstract][Full Text] [Related]
30. [Design and implementation of real-time control of changes to national Chinese medicine resources fill system based on GIS].
Zhang T; Li JD; Cheng M; Li Y; Lin ZB; Shen YH; Huang LQ
Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(22):4306-4309. PubMed ID: 29318826
[TBL] [Abstract][Full Text] [Related]
31. [Summary and analysis of safety warning on clinical application of anti-cold Chinese patent medicine preparations].
Lai XX; Lin H; Luo YN; Wang YY; Duan XH; Wang L; Luo R; Chen YH
Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1594-600. PubMed ID: 26281605
[TBL] [Abstract][Full Text] [Related]
32. [Present situation and prospect of quality standardization of Chinese patent medicines].
Gao XM; Zhang JJ; Zhang DQ; Wang JX; Ou LN; Chen SH
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):868-72. PubMed ID: 17639993
[TBL] [Abstract][Full Text] [Related]
33. [Application characteristics and situation analysis of volatile oils in database of Chinese patent medicine].
Wang SJ; Wu ZF; Yang M; Wang YQ; Hu PY; Jie XL; Han F; Wang F
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3379-83. PubMed ID: 25522633
[TBL] [Abstract][Full Text] [Related]
34. [Study on establishing a methodology of comprehensive clinical evaluation for Chinese patent medicine based on health technology assessment].
Liao X; Guo WD; Cao Z; Xu HY; Zhang YL; Zhao H; Wang YY
Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(16):3749-3758. PubMed ID: 32893567
[TBL] [Abstract][Full Text] [Related]
35. [Thoughts on post-marketing evaluation of classical Chinese patent medicines based on clinical value].
Song Z; Wang ZF; Wu Y; Xie YM; Yang YF; Xu Y
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1988-1993. PubMed ID: 33982509
[TBL] [Abstract][Full Text] [Related]
36. A novel classification method for aid decision of traditional Chinese patent medicines for stroke treatment.
Zhao Y; Liu B; He L; Bai W; Yu X; Cao X; Luo L; Rong P; Zhao Y; Li G; Liu B
Front Med; 2017 Sep; 11(3):432-439. PubMed ID: 28500428
[TBL] [Abstract][Full Text] [Related]
37. [Simultaneous determination of four highly polar anti-diabetic drugs in Chinese traditional patent medicines using high performance liquid chromatography].
Guo D; Nashunchaoketu ; Wang J; Liu X; Wu S; Zhao X; Yang B
Se Pu; 2009 Mar; 27(2):211-5. PubMed ID: 19626851
[TBL] [Abstract][Full Text] [Related]
38. [Formation and definition of Dao-di herbs："Wan medicines"].
Peng HS; Wang DQ; Peng DY
Zhongguo Zhong Yao Za Zhi; 2017 May; 42(9):1617-1622. PubMed ID: 29082678
[TBL] [Abstract][Full Text] [Related]
39. [Preliminary study on general safe medication regularity of Chinese patent orthopedic medicines based on adverse reaction/event literature analysis].
Wang YG; Shi XY; Jin R; Li HY; Kong XW; Qiao YJ
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1192-7. PubMed ID: 26226769
[TBL] [Abstract][Full Text] [Related]
40. [Industry of traditional Chinese patent medicine science and technology development and review].
Lu J; Wang F; Yan D; Luo Y; Yang M
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):5-8. PubMed ID: 22741452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
